Form 4 for NUTX Nutex Health Inc.
Accepted 2022-08-02 00:00:00 ET · period of report 2022-04-02 · accession 0001062993-22-017071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-02 | 2022-04-02 | NUTX | Schimmel Lawrence | Chief Medical Information Off | X - OptEx | $1.55 | +9,799 | 263.4K | +4% | +$15.2K |
| D | 2022-08-02 | 2022-04-02 | NUTX | Schimmel Lawrence | Chief Medical Information Off | C - Cnv Deriv | $1.55 | +19.6K | 253.6K | +8% | +$30.4K |
| D | 2022-08-02 | 2022-04-02 | NUTX | Schimmel Lawrence | Chief Medical Information Off | C - Cnv Deriv | $100,000.00 | -30.4K | 0 | -100% | -$3.04B |
| D | 2022-08-02 | 2022-04-02 | NUTX | Schimmel Lawrence | Chief Medical Information Off | X - OptEx | $0.00 | -9,799 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-02 | X | A | 9,799 | $1.55 | 263,444 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-02 | C | A | 19,597 | $1.55 | 253,645 | D | — | — | |
| 3 | Derivative | Convertible Promissory Note | 2022-04-02 | C | D | 30,375.35 | $100,000.00 | 0 | D | $1.55 · 2019-11-19 to 2022-07-31 | 19,597 Common Stock | (F1) Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. |
| 4 | Derivative | Warrant | 2022-04-02 | X | D | 9,799 | $0.00 | 0 | D | $1.55 · 2019-11-19 to 2022-07-31 | 9,799 Common Stock | (F2) Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. |